Publications

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

Download PDF
Resource: Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

.

Related Articles

Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

Link
The promise and challenge of spatial omics in dissecting tumour microenvironment and the role of AI

Link